Stockreport

BRIEF-Roche: FDA Grants Priority Review To Genentech’S Entrectinib [Reuters]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF BRIEF-Roche: FDA Grants Priority Review To Genentech’S Entrectinib | Reuters 1 Min Read Feb 19 (Reuters) - Roche Holding AG: * GENENTECH ANNOUNCED THAT U.S. FOOD AND DRU [Read more]